Headlines

Netherlands pushes for more generic drug imports from India

Published by Global Banking & Finance Review

Posted on September 5, 2025

2 min read

· Last updated: January 22, 2026

Add as preferred source on Google
Trump discusses land swaps for peace between Ukraine and Russia - Global Banking & Finance Review
Image depicting Donald Trump announcing his proposal for land swaps to achieve peace between Ukraine and Russia, amidst ongoing conflict. This moment highlights his diplomatic approach to resolving tensions in Eastern Europe.
Global Banking & Finance Awards 2026 — Call for Entries

By Rishika Sadam and Sriparna Roy NEW DELHI (Reuters) -The Netherlands is aiming to increase imports of Indian generic drugs into the country, as it looks to diversify its portfolio and avoid supply

Netherlands Seeks to Boost Imports of Indian Generic Medications

Netherlands' Strategy for Drug Import Diversification

By Rishika Sadam and Sriparna Roy

Current State of Generic Drug Market

NEW DELHI (Reuters) -The Netherlands is aiming to increase imports of Indian generic drugs into the country, as it looks to diversify its portfolio and avoid supply constraints, Dutch government officials and industry experts said at an event on Friday.

Training and Regulatory Collaboration

India, popularly referred to as the 'pharmacy of the world, exported $616 million worth of drugs in fiscal year 2025 to the Netherlands, making it India's seventh largest export market.

Future Prospects for Indian Exports

The biggest market for India is the U.S., where tariff concerns linger. India mostly exports generic drugs that are cheaper versions of popular innovative drugs.

"The Netherlands has a generic uptake of 80% for annual prescriptions... Four out of 5 medicines going to patients are generic drugs," Kayleigh van Winssen, deputy director of pharmaceutical affairs at the Netherlands ministry of health, said at the International Pharmaceutical Exhibition in New Delhi.

There are over 22,000 medicines authorized for use in the Netherlands, she noted.

The European nation encouraged Indian drug manufacturers to increase exports to the Netherlands and across therapy areas.

The Netherlands delegation said at the event that the country is looking to diversify its portfolio and reduce dependence on single drug suppliers or those with extremely high market share.

There has been a 50% drop in generic medicine registrations in the last five years, with fewer generic products in the market, according to Leon Tinke, managing director of BENU, one of the largest pharmacy chains in the Netherlands.

Under an existing agreement between India and the Netherlands, the countries have been collaborating to train inspectors to learn about the regulatory process.

"Indian inspectors (are) being trained in the Netherlands from both the national and state level...We already had a training in January and other trainings are being lined up," said Winssen.

"We are also thinking about how we can provide companies with better information," she said.

(Reporting by Rishika Sadam and Sriparna Roy in New Delhi; Editing by Shinjini Ganguli)

Key Takeaways

  • The Netherlands plans to boost imports of Indian generic drugs.
  • India exported $616 million worth of drugs to the Netherlands in 2025.
  • The Netherlands seeks to diversify its pharmaceutical portfolio.
  • There has been a 50% drop in generic medicine registrations in five years.
  • India and the Netherlands collaborate on regulatory training.

Frequently Asked Questions

What is the Netherlands' goal regarding Indian generic drugs?
The Netherlands aims to increase imports of Indian generic drugs to diversify its portfolio and avoid supply constraints.
How much did India export in drugs to the Netherlands in fiscal year 2025?
India exported $616 million worth of drugs to the Netherlands in fiscal year 2025, making it India's seventh largest export market.
What percentage of annual prescriptions in the Netherlands are generic drugs?
The Netherlands has a generic uptake of 80% for annual prescriptions, meaning four out of five medicines going to patients are generic.
What challenges are faced in the registration of generic medicines?
There has been a 50% drop in generic medicine registrations in the last five years, leading to fewer generic products in the market.
What collaboration exists between India and the Netherlands regarding drug regulation?
Under an existing agreement, India and the Netherlands are collaborating to train inspectors about the regulatory process.

Tags

Related Articles

More from Headlines

Explore more articles in the Headlines category